Brief ReportBrief Report
Anti-HMGCR Myopathy: A Rare and Serious Side Effect of Statins
Nathaniel J. Irvine
The Journal of the American Board of Family
Medicine September 2020, 33 (5) 785-788; DOI: https://doi.org/10.3122/jabfm.2020.05.190450
Nathaniel J. Irvine
From the Naval Health Clinic New England, Portsmouth, NH, USA.
MDReferences
- 1.↵
- 2.↵
- Pinal-Fernandez I,
- Casal-Dominguez M,
- Mammen AL
- 3.↵
- Carvalho AAS,
- Silva VGD,
- Vieira TF,
- et al
- 4.↵
- Tournadre A
- 5.↵
- Adler BL,
- Christopher-Stine L
- 6.↵
- Upreti S,
- Fayyaz B,
- Bongu RP
- 7.↵
- Ayesha SM,
- Meena AK,
- Vangala N,
- et al
- 8.↵
- 9.↵
- Mohassel P,
- Mammen AL
- 10.↵
- Basharat P,
- Lahouti AH,
- Paik JJ,
- et al
- 11.↵
- Allenbach Y,
- Mammen AL,
- Benveniste O,
- et al
- 12.↵
- Palterer B,
- Vitiello G,
- Carraresi A,
- Giudizi MG,
- Cammelli D,
- Parronchi P
- 13.↵
- Christopher-Stine L,
- Casciola-Rosen LA,
- Hong G,
- Chung T,
- Corse AM,
- Mammen AA
- 14.↵
In this issue
The Journal of the American Board of Family
Medicine
Vol. 33, Issue 5
September/October 2020
Anti-HMGCR Myopathy: A Rare and Serious Side Effect of Statins
Nathaniel J. Irvine
The Journal of the American Board of Family
Medicine Sep 2020, 33 (5) 785-788; DOI: 10.3122/jabfm.2020.05.190450
Jump to section
Related Articles
- No related articles found.